CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 69 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2021. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $426,973 | -23.6% | 490,690 | -1.7% | 0.00% | – |
| Q2 2023 | $559,111 | +1.4% | 499,207 | -5.8% | 0.00% | – |
| Q1 2023 | $551,300 | +92868.0% | 530,097 | 0.0% | 0.00% | – |
| Q4 2022 | $593 | -99.9% | 530,097 | +0.9% | 0.00% | – |
| Q3 2022 | $593,000 | -23.0% | 525,307 | +0.3% | 0.00% | – |
| Q2 2022 | $770,000 | -31.3% | 523,991 | +7.0% | 0.00% | – |
| Q1 2022 | $1,121,000 | -16.2% | 489,929 | +0.7% | 0.00% | – |
| Q4 2021 | $1,338,000 | -54.2% | 486,642 | 0.0% | 0.00% | – |
| Q3 2021 | $2,919,000 | +41.6% | 486,642 | +14.9% | 0.00% | – |
| Q2 2021 | $2,062,000 | +129.1% | 423,541 | +16.1% | 0.00% | – |
| Q1 2021 | $900,000 | +0.8% | 364,723 | +11.8% | 0.00% | – |
| Q4 2020 | $893,000 | +77.9% | 326,195 | 0.0% | 0.00% | – |
| Q3 2020 | $502,000 | -18.1% | 326,195 | 0.0% | 0.00% | – |
| Q2 2020 | $613,000 | +10.6% | 326,195 | 0.0% | 0.00% | – |
| Q1 2020 | $554,000 | -65.4% | 326,195 | -40.9% | 0.00% | – |
| Q4 2019 | $1,600,000 | +939.0% | 552,070 | +125.2% | 0.00% | – |
| Q3 2019 | $154,000 | -35.6% | 245,179 | -0.3% | 0.00% | – |
| Q2 2019 | $239,000 | -45.8% | 245,988 | -23.0% | 0.00% | – |
| Q1 2019 | $441,000 | -31.9% | 319,590 | -47.4% | 0.00% | – |
| Q4 2018 | $648,000 | -63.6% | 607,024 | +109.8% | 0.00% | -100.0% |
| Q3 2018 | $1,779,000 | -39.5% | 289,331 | +5.2% | 0.00% | 0.0% |
| Q2 2018 | $2,940,000 | +12.9% | 275,041 | +13.3% | 0.00% | 0.0% |
| Q1 2018 | $2,605,000 | +186.9% | 242,839 | +87.0% | 0.00% | – |
| Q4 2017 | $908,000 | -17.5% | 129,847 | +3.0% | 0.00% | – |
| Q3 2017 | $1,101,000 | -1.8% | 126,086 | +2.4% | 0.00% | – |
| Q2 2017 | $1,121,000 | +46.7% | 123,085 | +27.8% | 0.00% | – |
| Q1 2017 | $764,000 | -5.8% | 96,324 | +6.2% | 0.00% | – |
| Q4 2016 | $811,000 | +11.1% | 90,728 | +115.6% | 0.00% | – |
| Q3 2016 | $730,000 | – | 42,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |